Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

A long-term trial of the effectiveness and safety of atypical antipsychotic agents in augmenting SSRI-refractory obsessive-compulsive disorder.

Matsunaga H, Nagata T, Hayashida K, Ohya K, Kiriike N, Stein DJ.

J Clin Psychiatry. 2009 Jun;70(6):863-8. doi: 10.4088/JCP.08m04369. Epub 2009 May 5.

PMID:
19422759
2.

A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder.

Bloch MH, Landeros-Weisenberger A, Kelmendi B, Coric V, Bracken MB, Leckman JF.

Mol Psychiatry. 2006 Jul;11(7):622-32. Epub 2006 Apr 4. Review. Erratum in: Mol Psychiatry. 2006 Aug;11(8):795.

PMID:
16585942
3.

Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.

Dold M, Aigner M, Lanzenberger R, Kasper S.

Int J Neuropsychopharmacol. 2013 Apr;16(3):557-74. doi: 10.1017/S1461145712000740. Epub 2012 Aug 29. Review.

PMID:
22932229
4.

Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis.

Veale D, Miles S, Smallcombe N, Ghezai H, Goldacre B, Hodsoll J.

BMC Psychiatry. 2014 Nov 29;14:317. doi: 10.1186/s12888-014-0317-5. Review.

5.

[Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].

Ammar G, Naja WJ, Pelissolo A.

Encephale. 2015 Jun;41(3):260-5. doi: 10.1016/j.encep.2013.11.002. Epub 2014 Nov 14. Review. French.

PMID:
25439852
6.

Second-generation antipsychotics for obsessive compulsive disorder.

Komossa K, Depping AM, Meyer M, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2010 Dec 8;(12):CD008141. doi: 10.1002/14651858.CD008141.pub2. Review.

PMID:
21154394
7.

Do antipsychotics ameliorate or exacerbate Obsessive Compulsive Disorder symptoms? A systematic review.

Sareen J, Kirshner A, Lander M, Kjernisted KD, Eleff MK, Reiss JP.

J Affect Disord. 2004 Oct 15;82(2):167-74. Review.

PMID:
15488245
8.

Assessment and management of treatment-refractory obsessive-compulsive disorder in children.

Bloch MH, Storch EA.

J Am Acad Child Adolesc Psychiatry. 2015 Apr;54(4):251-62. doi: 10.1016/j.jaac.2015.01.011. Epub 2015 Jan 30. Review.

9.

Issues in the pharmacological treatment of obsessive-compulsive disorder.

Math SB, Janardhan Reddy YC.

Int J Clin Pract. 2007 Jul;61(7):1188-97. Epub 2007 May 18. Review.

PMID:
17511795
10.

[A Review and Recommendations of Evidence-Based Treatments for Pediatric Obsessive-Compulsive Disorder].

Skarphedinsson G, Lauth B, Njardvik U, Ivarsson T.

Laeknabladid. 2016 Apr;102(4):179-85. doi: 10.17992/lbl.2016.04.75. Review. Icelandic.

PMID:
27197125
11.

[Efficacy of antipsychotic augmentation therapy in treatment-resistant obsessive-compulsive disorder: a meta-analysis of double-blind, randomised, placebo-controlled trials].

Dold M, Aigner M, Lanzenberger R, Kasper S.

Fortschr Neurol Psychiatr. 2011 Aug;79(8):453-66. doi: 10.1055/s-0031-1273397. Epub 2011 Aug 1. Review. German.

PMID:
21809258
12.

Summary of the comparative effectiveness review on off-label use of atypical antipsychotics.

Maher AR, Theodore G.

J Manag Care Pharm. 2012 Jun;18(5 Suppl B):S1-20. Review.

PMID:
22784311
13.

[Evidence-based pharmacotherapy and other somatic treatment approaches for obsessive-compulsive disorder: state of the art].

Kordon A, Zurowski B, Wahl K, Hohagen F.

Nervenarzt. 2011 Mar;82(3):319-20, 322-4. doi: 10.1007/s00115-010-2963-2. Review. German.

PMID:
21340636
14.

[Augmentation of selective serotonin reuptake inhibitors (SSRI) with atypical antipsychotics in the treatment of depression].

Weimer E, Braus DF, Cavus I, Thome J.

Fortschr Neurol Psychiatr. 2002 Apr;70(4):210-7. Review. German.

PMID:
11948436
15.

Antipsychotic treatment in obsessive-compulsive disorder: a literature review.

Keuneman RJ, Pokos V, Weerasundera R, Castle DJ.

Aust N Z J Psychiatry. 2005 May;39(5):336-43. Review.

PMID:
15860020
16.

Efficacy of treatments for patients with obsessive-compulsive disorder: a systematic review.

Choi YJ.

J Am Acad Nurse Pract. 2009 Apr;21(4):207-13. doi: 10.1111/j.1745-7599.2009.00408.x. Review.

PMID:
19366379
17.

The medical treatment of obsessive-compulsive disorder and anxiety.

Bandelow B.

CNS Spectr. 2008 Sep;13(9 Suppl 14):37-46. Review.

PMID:
18849910
18.

Refractory obsessive-compulsive disorder: state-of-the-art treatment.

Hollander E, Bienstock CA, Koran LM, Pallanti S, Marazziti D, Rasmussen SA, Ravizza L, Benkelfat C, Saxena S, Greenberg BD, Sasson Y, Zohar J.

J Clin Psychiatry. 2002;63 Suppl 6:20-9. Review.

19.

[Diversity of obsessive-compulsive disorder and pharmacotherapy associated with obsessive-compulsive spectrum disorders].

Nakamae T.

Seishin Shinkeigaku Zasshi. 2011;113(10):1016-25. Review. Japanese.

PMID:
22187889
20.

Pharmacological management of obsessive-compulsive disorder: a review for clinicians.

McDonough M, Kennedy N.

Harv Rev Psychiatry. 2002 May-Jun;10(3):127-37. Review.

PMID:
12023928

Supplemental Content

Support Center